PANZOMORE D

Composition:

• Active Ingredients:

  • Pantoprazole: 40 mg

  • Domperidone: 10 mg

Formulation:

• Form: Tablet

• Dosage Strengths:

  • Pantoprazole 40 mg

  • Domperidone 10 mg

• Route of Administration: Oral

Status:

• Prescription Status: Prescription-only medication (Rx)

• Regulatory Approval: Approved by drug regulatory authorities (such as the FDA or equivalent) for the management of acid-related gastrointestinal conditions and associated symptoms.

Benefits:

• Acid Reduction and Gastrointestinal Relief:

  • Pantoprazole: A proton pump inhibitor (PPI) that reduces stomach acid production, helping to manage conditions such as GERD, peptic ulcers, and acid-related damage.

  • Domperidone: A dopamine antagonist that helps to increase gastric motility and reduce symptoms such as nausea, vomiting, and bloating. It improves the movement of food through the digestive tract.

• Comprehensive Gastrointestinal Management:

  • Pantoprazole reduces acid production, which helps heal and protect the esophagus and stomach lining from acid-related damage.

  • Domperidone addresses symptoms like nausea and bloating, which can accompany acid-related conditions.

• Symptom Relief:

  • Pantoprazole provides relief from heartburn, acid regurgitation, and discomfort associated with excessive stomach acid.

  • Domperidone helps alleviate gastrointestinal symptoms such as nausea and vomiting, making it particularly useful for patients with mixed symptoms of acid-related disorders and gastric motility issues.

• Improved Quality of Life: By addressing both acid production and gastrointestinal motility, Panzomore D provides a more comprehensive approach to managing symptoms and improving overall quality of life for patients with acid-related conditions and associated symptoms.